vTv Therapeutics (VTVT) news
Recent news
Google built-in now spans 16 brands, 100+ car models
Google's integration of its Android-based infotainment system into the automotive industry has expanded significantly, now spanning 16 car brands and over 100 vehicle models. This development marks a major milestone in the company's strategy to establish a dominant presence in the connected car…
AInvest Wire · 2d agoAdvancedAdvt Ltd: Hy trading remains in line with management expectations
AdvancedAdvt Ltd (ADVT) continues to report trading performance consistent with management expectations, with no significant deviations noted in recent operations. The company recently completed a share buyback of 243,453 shares , reflecting its ongoing commitment to managing capital structure and…
AInvest Wire · 3d agoVTV Therapeutics announces inducement grants under Nasdaq listing rule 5635(C)(4)
AInvest Wire · Sep 15, 2026VTV Therapeutics, Inc.: H.C. Wainwright cuts target price to $42 from $45
AInvest Wire · Aug 6, 2026VTV Therapeutics Inc: BTIG raises target price to $57 from $49
BTIG has raised its price target for vTv Therapeutics Inc. (NASDAQ: VTVT) to $57 from $49, while maintaining its Buy rating on the stock. The firm highlighted the company’s broader pipeline potential beyond its lead diabetes program, cadisegliatin, which is currently in Phase 3 trials for Type 1…
AInvest Wire · Jul 16, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.